In Vivo Determination and Pharmacokinetics Analysis of Arotinolol Enantiomers in Wistar Rats

许艳海,陈朗东,方俊聪,郑乐艺,张劲柏,闻俊,洪战英,柴逸峰,范国荣
DOI: https://doi.org/10.16155/j.0254-1793.2015.09.05
2015-01-01
Abstract:Objective: To establish a method for the determination of arotinolol enantiomers in rat plasma,and to study its pharmacokinetic features in Wistar rats. Methods: The plasma samples were pretreated with liquid-liquid extraction. The concentrations of arotinolol enantiomers in rat plasma were determined by HPLC with Chiralpak AD-H column( 250 mm × 4. 6 mm,5 μm) and UV detector. The mobile phase consisted of hexane-ethanol-diethylamine-triethylamine( 30∶ 70∶ 0. 1 ∶ 0. 1),with a flow rate of 0. 4 m L·min- 1. The detection wavelength was set at 315 nm. Results: Good linear relationship was obtained in the range of 0. 025-1. 25 μg·m L- 1( r2> 0. 99).The recoveries of arotinolol enantiomers were above 94. 1%. The intra-day and inter-day RSD for arotinolol were lower than 15%. After intragastric administration,the Cmaxand AUC0- ∞of d-arotinolol were 0. 225 μg·m L- 1and1. 82 μg·h·m L- 1,respectively. The Cmaxand AUC0- ∞of l-arotinolol were 0. 226 μg·m L- 1and 1. 84 μg·h·m L- 1,respectively. Conclusion: The established method is proved suitable for the pharmacokinetic study of arotinolol in Wistar rats. In addition,our results indicate that arotinolol enantiomers have no chiral selectivity in Wistar rats.
What problem does this paper attempt to address?